Zoladex

Zoladex Brand names, Zoladex Analogs

Zoladex Brand Names Mixture

Fluoracaine Oph Soln (Fluorescein Sodium + Proxymetacain Hcl)
Fluorescein Sodium & Benoxinate Hydrochloride Ophtalmic Solution, Usp (Benoxinate Hydrochloride + Fluorescein Sodium)
Fluress (Benoxinate Hydrochloride + Fluorescein Sodium)
Fluress Liq Oph (Benoxinate Hydrochloride + Fluorescein Sodium)

Zoladex Chemical_Formula

C₅₉H₈₄N₁₈O₁₄

Zoladex RX_link

http://www.rxlist.com/cgi/generic/goserel.htm

Zoladex fda sheet

Zoladex FDA

Zoladex msds (material safety sheet)

Zoladex Synthesis Reference

Weber et al., U.S. Pat. 3,454,635 (1969)

Zoladex Molecular Weight

1269.41 g/mol

Zoladex Melting Point

No information avaliable

Zoladex H₂O Solubility

Soluble

Zoladex State

Solid

Zoladex LogP

-2.517

Zoladex Dosage Forms

Supplied as a sterile and totally biodegradable d,l-lactic and glycolic acids copolymer (13.3-14.3 mg/dose) impregnated with goserelin acetate equivalent to 3.6 mg of goserelin in a disposable syringe device fitted with a 16-gauge hypodermic needle

Zoladex Indication

Breast cancer; Prostate carcinoma; Endometriosis

Zoladex Pharmacology

The pharmacokinetics of ZOLADEX have been determined in both male and female healthy volunteers and patients. In these studies, ZOLADEX was administered as a single 250µg (aqueous solution) dose and as a single or multiple 3.6 mg depot dose by subcutaneous route.

Zoladex Absorption

Inactive orally, rapidly absorbed following subcutaneous administration

Zoladex side effects and Toxicity

No experience of overdosage from clinical trials

Zoladex Patient Information

BIOD00113.html

Zoladex Organisms Affected

Humans and other mammals